Progressive dysfunction of the cholesterol biosynthesis pathway in the R6/2 mouse model of Huntington’s disease
暂无分享,去创建一个
C. Mariotti | S. Donato | A. Tarditi | E. Cattaneo | M. Valenza | I. Björkhem | V. Leoni
[1] M. Hayden,et al. Cholesterol biosynthesis pathway is disturbed in YAC128 mice and is modulated by huntingtin mutation. , 2007, Human molecular genetics.
[2] A. Ogura,et al. Brain-Derived Neurotrophic Factor Regulates Cholesterol Metabolism for Synapse Development , 2007, The Journal of Neuroscience.
[3] Vijay H Shah,et al. Mutant huntingtin inhibits clathrin-independent endocytosis and causes accumulation of cholesterol in vitro and in vivo. , 2006, Human molecular genetics.
[4] I. Björkhem,et al. Crossing the barrier: oxysterols as cholesterol transporters and metabolic modulators in the brain , 2006, Journal of internal medicine.
[5] E. Cattaneo,et al. Cholesterol dysfunction in neurodegenerative diseases: Is Huntington's disease in the list? , 2006, Progress in Neurobiology.
[6] M. Resh,et al. Trafficking and signaling by fatty-acylated and prenylated proteins , 2006, Nature chemical biology.
[7] L. K. Marriott,et al. Multiple pathways transmit neuroprotective effects of gonadal steroids , 2006, Endocrine.
[8] P. Calabresi,et al. Plastic and behavioral abnormalities in experimental Huntington's disease: A crucial role for cholinergic interneurons , 2006, Neurobiology of Disease.
[9] Brad E. Pfeiffer,et al. Brain cholesterol turnover required for geranylgeraniol production and learning in mice. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[10] Elena Cattaneo,et al. Normal huntingtin function: an alternative approach to Huntington's disease , 2005, Nature Reviews Neuroscience.
[11] J. Olson,et al. Dysfunction of the Cholesterol Biosynthetic Pathway in Huntington's Disease , 2005, The Journal of Neuroscience.
[12] F. Sundler,et al. Reduction of GnRH and infertility in the R6/2 mouse model of Huntington's disease , 2005, The European journal of neuroscience.
[13] Klaus-Armin Nave,et al. High cholesterol level is essential for myelin membrane growth , 2005, Nature Neuroscience.
[14] M. Panas,et al. Plasma testosterone in male patients with Huntington's disease: Relations to severity of illness and dementia , 2005, Annals of neurology.
[15] S. Pfeffer,et al. Targeting Rab GTPases to distinct membrane compartments , 2004, Nature Reviews Molecular Cell Biology.
[16] J. Dietschy,et al. Thematic review series: Brain Lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal Published, JLR Papers in Press, May 16, 2004. DOI 10.1194/jlr.R400004-JLR200 , 2004, Journal of Lipid Research.
[17] Thomas Wichmann,et al. Role of External Pallidal Segment in Primate Parkinsonism: Comparison of the Effects of 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Parkinsonism and Lesions of the External Pallidal Segment , 2004, The Journal of Neuroscience.
[18] Steve Meaney,et al. Brain Cholesterol: Long Secret Life Behind a Barrier , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[19] M. Endres,et al. HMG‐CoA reductase inhibition causes neurite loss by interfering with geranylgeranylpyrophosphate synthesis , 2004, Journal of neurochemistry.
[20] J. Dietschy,et al. Ontogenesis and regulation of cholesterol metabolism in the central nervous system of the mouse. , 2003, Brain research. Developmental brain research.
[21] D. Russell,et al. Knockout of the Cholesterol 24-Hydroxylase Gene in Mice Reveals a Brain-specific Mechanism of Cholesterol Turnover* , 2003, Journal of Biological Chemistry.
[22] F. Pfrieger,et al. Cholesterol homeostasis and function in neurons of the central nervous system , 2003, Cellular and Molecular Life Sciences CMLS.
[23] D. Stein. Brain damage, sex hormones and recovery: a new role for progesterone and estrogen? , 2001, Trends in Neurosciences.
[24] Blair R. Leavitt,et al. Loss of Huntingtin-Mediated BDNF Gene Transcription in Huntington's Disease , 2001, Science.
[25] S. Oliverio,et al. Early Alterations in Gene Expression and Cell Morphology in a Mouse Model of Huntington's Disease , 2000, Journal of neurochemistry.
[26] S. W. Davies,et al. Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington's disease. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[27] J M Guileyardo,et al. cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[28] Claire-Anne Gutekunst,et al. A YAC Mouse Model for Huntington’s Disease with Full-Length Mutant Huntingtin, Cytoplasmic Toxicity, and Selective Striatal Neurodegeneration , 1999, Neuron.
[29] Nasreen S Jessani,et al. Characterization of UT2 Cells , 1997, The Journal of Biological Chemistry.
[30] P. Casey,et al. Influence of metal ions on substrate binding and catalytic activity of mammalian protein geranylgeranyltransferase type-I. , 1996, The Biochemical journal.
[31] S. W. Davies,et al. Exon 1 of the HD Gene with an Expanded CAG Repeat Is Sufficient to Cause a Progressive Neurological Phenotype in Transgenic Mice , 1996, Cell.
[32] K. Kristensson,et al. The lipid compositions of different regions of rat brain during development and aging , 1996, Neurobiology of Aging.
[33] D. Lütjohann,et al. Cholesterol homeostasis in human brain: evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[34] P. Morell,et al. Origin of cholesterol in myelin , 1996, Neurochemical Research.
[35] T. Chojnacki,et al. Distribution of Branch Point Prenyltransferases in Regions of Bovine Brain , 1995, Journal of neurochemistry.
[36] Manish S. Shah,et al. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes , 1993, Cell.
[37] K. Kristensson,et al. Rates of cholesterol, ubiquinone, dolichol and dolichyl‐P biosynthesis in rat brain slices , 1990, FEBS letters.
[38] J. Goldstein,et al. Regulation of the mevalonate pathway , 1990, Nature.
[39] L. M. Morales,et al. Nutritional evaluation of Huntington disease patients. , 1989, The American journal of clinical nutrition.
[40] H. Kempen,et al. Serum lathosterol concentration is an indicator of whole-body cholesterol synthesis in humans. , 1988, Journal of lipid research.
[41] R. Ferrante,et al. Neuropathological Classification of Huntington's Disease , 1985, Journal of neuropathology and experimental neurology.
[42] R. Heller,et al. 3-hydroxy-3-methylglutaryl coenzyme A reductase in human liver microsomes: active and inactive forms and cross-reactivity with antibody against rat liver enzyme. , 1984, Journal of lipid research.
[43] W. Maltese. Cholesterol synthesis in cultured skin fibroblasts from patients with Huntington's disease. , 1984, Biochemical medicine.
[44] J. Mandel,et al. Total serum cholesterol by isotope dilution/mass spectrometry: a candidate definitive method. , 1980, Clinical chemistry.
[45] M. Brown,et al. Active and inactive forms of 3-hydroxy-3-methylglutaryl coenzyme A reductase in the liver of the rat. Comparison with the rate of cholesterol synthesis in different physiological states. , 1979, The Journal of biological chemistry.
[46] J. Menkes,et al. Huntington's disease—growth of fibroblast cultures in lipid‐deficient medium: A preliminary report , 1977, Annals of neurology.
[47] G. Bruyn,et al. Biochemical studies in Huntington's chorea , 1968, Neurology.
[48] B. Connors,et al. Functional Properties of Electrical Synapses between Inhibitory Interneurons of Neocortical Layer 4 , 2022 .
[49] J. Menkes,et al. Huntington's disease: growth and fatty acid metabolism of fibroblast cultures in lipid-deficient medium. , 1976, Transactions of the American Neurological Association.